BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27430874)

  • 21. Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies.
    Suzuki H; Fujimoto M; Kawakita F; Liu L; Nakatsuka Y; Nakano F; Nishikawa H; Okada T; Kanamaru H; Imanaka-Yoshida K; Yoshida T; Shiba M
    J Neurosci Res; 2020 Jan; 98(1):42-56. PubMed ID: 30242870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Badjatia N; Carpenter A; Fernandez L; Schmidt JM; Mayer SA; Claassen J; Lee K; Connolly ES; Seres D; Elkind MS
    Stroke; 2011 Sep; 42(9):2436-42. PubMed ID: 21757662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage.
    Beadell NC; Thompson EM; Delashaw JB; Cetas JS
    J Neurosurg; 2012 Oct; 117(4):781-6. PubMed ID: 22920957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isofurans and Isoprostanes as Potential Markers of Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Study.
    Gomes JA; Milne G; Kallianpur A; Shriver L
    Neurocrit Care; 2022 Feb; 36(1):202-207. PubMed ID: 34286463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboelastography Parameter Predicts Outcome After Subarachnoid Hemorrhage: An Exploratory Analysis.
    Ramchand P; Nyirjesy S; Frangos S; Doerfler S; Nawalinski K; Quattrone F; Ju C; Patel H; Driscoll N; Maloney-Wilensky E; Stein SC; Levine JM; Kasner SE; Kumar MA
    World Neurosurg; 2016 Dec; 96():215-221. PubMed ID: 27072337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Neurofilament Light Chain Is Associated with Poor Functional Outcome and Mortality Rate After Spontaneous Subarachnoid Hemorrhage.
    Hviid CVB; Lauridsen SV; Gyldenholm T; Sunde N; Parkner T; Hvas AM
    Transl Stroke Res; 2020 Aug; 11(4):671-677. PubMed ID: 31808039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria.
    Zhang Z; Zhang A; Liu Y; Hu X; Fang Y; Wang X; Luo Y; Lenahan C; Chen S
    Curr Neuropharmacol; 2022; 20(7):1278-1296. PubMed ID: 34720082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Utility of Ankle-Brachial Index as a Predictor of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
    Guan J; Karsy M; Brock A; Couldwell WT
    World Neurosurg; 2016 May; 89():139-46. PubMed ID: 26828462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADMA levels and arginine/ADMA ratios reflect severity of disease and extent of inflammation after subarachnoid hemorrhage.
    Lindgren C; Hultin M; Koskinen LO; Lindvall P; Borota L; Naredi S
    Neurocrit Care; 2014 Aug; 21(1):91-101. PubMed ID: 24408146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE
    J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 32. Loss of Consciousness at Onset of Aneurysmal Subarachnoid Hemorrhage is Associated with Functional Outcomes in Good-Grade Patients.
    Wang J; Alotaibi NM; Akbar MA; Ayling OG; Ibrahim GM; Macdonald RL;
    World Neurosurg; 2017 Feb; 98():308-313. PubMed ID: 27818312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Plasma Galectin-3 Preceding the Development of Delayed Cerebral Infarction and Eventual Poor Outcome in Non-Severe Aneurysmal Subarachnoid Hemorrhage.
    Nishikawa H; Nakatsuka Y; Shiba M; Kawakita F; Fujimoto M; Suzuki H;
    Transl Stroke Res; 2018 Apr; 9(2):110-119. PubMed ID: 28831694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early platelet activation, inflammation and acute brain injury after a subarachnoid hemorrhage: a pilot study.
    Frontera JA; Aledort L; Gordon E; Egorova N; Moyle H; Patel A; Bederson JB; Sehba F
    J Thromb Haemost; 2012 Apr; 10(4):711-3. PubMed ID: 22309145
    [No Abstract]   [Full Text] [Related]  

  • 35. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Subarachnoid Hemorrhage Early Brain Edema Score Predicts Delayed Cerebral Ischemia and Clinical Outcomes.
    Ahn SH; Savarraj JP; Pervez M; Jones W; Park J; Jeon SB; Kwon SU; Chang TR; Lee K; Kim DH; Day AL; Choi HA
    Neurosurgery; 2018 Jul; 83(1):137-145. PubMed ID: 28973675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain injury visible on early MRI after subarachnoid hemorrhage might predict neurological impairment and functional outcome.
    De Marchis GM; Filippi CG; Guo X; Pugin D; Gaffney CD; Dangayach NS; Suwatcharangkoon S; Falo MC; Schmidt JM; Agarwal S; Connolly ES; Claassen J; Zhao B; Mayer SA
    Neurocrit Care; 2015 Feb; 22(1):74-81. PubMed ID: 25012392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of glutamate in brain injuries after subarachnoid hemorrhage.
    Kawakita F; Kanamaru H; Asada R; Suzuki Y; Nampei M; Nakajima H; Oinaka H; Suzuki H
    Histol Histopathol; 2022 Nov; 37(11):1041-1051. PubMed ID: 36065974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage.
    Juvela S; Kuhmonen J; Siironen J
    Acta Neurochir (Wien); 2012 Mar; 154(3):397-404. PubMed ID: 22134501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting neurological deficit severity due to subarachnoid haemorrhage: soluble CD40 ligand and platelet-derived growth factor-BB.
    Kubo Y; Koji T; Yoshida J; Ogawa A; Ogasawara K
    Crit Care Resusc; 2016 Dec; 18(4):242-246. PubMed ID: 27903205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.